Jefferies Financial Group Inc. Has $4.58 Million Stock Position in The Clorox Company (NYSE:CLX)

Jefferies Financial Group Inc. cut its stake in The Clorox Company (NYSE:CLX - Free Report) by 49.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,227 shares of the company's stock after selling 27,397 shares during the period. Jefferies Financial Group Inc.'s holdings in Clorox were worth $4,584,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Redwood Park Advisors LLC bought a new stake in Clorox in the fourth quarter worth about $26,000. Millstone Evans Group LLC bought a new position in shares of Clorox during the 4th quarter valued at about $31,000. Asset Planning Inc acquired a new position in shares of Clorox in the 4th quarter worth approximately $32,000. GKV Capital Management Co. Inc. bought a new stake in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Clorox in the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CLX shares. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. JPMorgan Chase & Co. reduced their price objective on Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research note on Tuesday, May 6th. Barclays decreased their target price on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. DA Davidson cut their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Finally, UBS Group decreased their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $151.23.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the transaction, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.57% of the company's stock.

Clorox Stock Up 0.6%

NYSE:CLX traded up $0.77 during trading hours on Friday, hitting $131.76. 2,492,574 shares of the company's stock traded hands, compared to its average volume of 1,342,489. The stock's fifty day moving average price is $138.50 and its two-hundred day moving average price is $151.47. The firm has a market cap of $16.24 billion, a P/E ratio of 36.00, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a twelve month low of $127.77 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox's revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.71 EPS. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.